Understanding Frontotemporal Dementia
Frontotemporal Dementia MRI vs Normal Comparison Frontotemporal dementia (FTD) is a neurodegenerative disease characterized by the progressive degeneration of the frontal and temporal lobes of the brain. This condition primarily affects behavior, language, and executive functioning, leading to significant changes in personality, language difficulties, and impaired decision-making abilities.
The progression of FTD is often gradual, with symptoms typically appearing between the ages of 40 and 65. Unlike other forms of dementia, such as Alzheimer’s disease, which primarily affects memory, FTD primarily affects behavior and language skills.
One of the key markers of frontotemporal dementia is frontotemporal lobe atrophy, which can be observed through brain imaging techniques, including magnetic resonance imaging (MRI). MRI scans allow healthcare professionals to visualize and compare the structural changes in the brain of individuals with FTD to those with a normal brain. Frontotemporal Dementia MRI vs Normal Comparison
Get Free Consultation
ACIBADEM Health Point: The Future of Healthcare
We believe that everyone deserves access to quality healthcare, which is why we have established multiple branches in strategic locations. Whether you're in need of routine check-ups, specialized treatments, or emergency care, ACIBADEM Health Point is here for you.Frontotemporal lobe atrophy comparison between the brain of an individual with FTD and a normal brain can reveal significant differences in brain structure and highlight the specific areas of degeneration. These changes in the frontotemporal lobes help differentiate FTD from other forms of dementia and provide valuable insights into the underlying pathology of the disease. Frontotemporal Dementia MRI vs Normal Comparison
It is worth noting that while MRI is a powerful tool in the diagnosis and understanding of frontotemporal dementia, it is not the sole diagnostic method. Healthcare professionals consider a comprehensive assessment that includes clinical evaluations, neuropsychological testing, and other diagnostic criteria to accurately diagnose FTD. Frontotemporal Dementia MRI vs Normal Comparison
The Role of MRI in Frontotemporal Dementia Diagnosis
Neuroimaging plays a crucial role in the diagnosis of frontotemporal dementia (FTD), allowing healthcare professionals to detect and evaluate the presence of the condition in patients. Among the various neuroimaging techniques, magnetic resonance imaging (MRI) stands out as a valuable tool in understanding the structural changes that occur in the brain. Frontotemporal Dementia MRI vs Normal Comparison
ACIBADEM Health Point: Your Health is Our Priority!
ACIBADEM Health Point, we are dedicated to providing exceptional healthcare services to our patients. With a team of highly skilled medical professionals and state-of-the-art facilities, we strive to deliver the highest standard of care to improve the health and well-being of our patients. What sets ACIBADEM Health Point apart is our patient-centered approach. We prioritize your comfort, safety, and satisfaction throughout your healthcare journey. Our compassionate staff ensures that you receive personalized care tailored to your unique needs, making your experience with us as seamless and comfortable as possible.At Acibadem Healthcare Group, our experts recognize the significance of MRI in FTD diagnosis. With years of experience and expertise in neuroimaging, our team utilizes state-of-the-art MRI technology to provide accurate and detailed scans that aid in detecting and monitoring FTD. Frontotemporal Dementia MRI vs Normal Comparison
By utilizing MRI scans, healthcare professionals can identify specific neuroimaging markers associated with frontotemporal dementia. These markers are crucial in distinguishing FTD from other types of dementia and identifying the areas of the brain affected by the disease. Frontotemporal Dementia MRI vs Normal Comparison
MRI scans provide detailed images of the brain’s structure, allowing healthcare professionals to observe frontotemporal lobe atrophy, a key characteristic of FTD. This atrophy, which refers to the shrinkage or loss of brain tissue in the frontotemporal regions, can be visualized through MRI as a notable difference compared to a normal brain. Frontotemporal Dementia MRI vs Normal Comparison
Furthermore, MRI aids in assessing the severity and progression of frontotemporal dementia. It allows healthcare professionals to track changes in brain structure over time, providing valuable insights into the disease’s course and enabling personalized treatment plans for patients. Frontotemporal Dementia MRI vs Normal Comparison
Advancements in Neuroimaging Techniques
Recent advancements in MRI technology have further enhanced the diagnostic capabilities for frontotemporal dementia. Advanced imaging protocols, such as diffusion tensor imaging (DTI), enable the visualization of microstructural changes in white matter tracts, providing additional insights into the progression of FTD.
Additionally, functional MRI (fMRI) offers the opportunity to assess the functional connectivity of the brain, helping to identify networks affected by FTD and potentially revealing biomarkers that could improve early detection and treatment strategies.
It is important to note that although MRI plays a significant role in frontotemporal dementia diagnosis, it is typically used in conjunction with other assessments, including clinical evaluations and neuropsychological testing. A comprehensive approach that combines different diagnostic tools ensures accurate and reliable diagnoses, facilitating optimal patient care.
Through the utilization of MRI and other neuroimaging techniques, healthcare professionals can confidently diagnose frontotemporal dementia and provide appropriate care and support for patients and their families.
Advantages of MRI in Frontotemporal Dementia Diagnosis
| Advantages |
|---|
| Accurate visualization of frontotemporal lobe atrophy |
| Evaluation of disease severity and progression |
| Identification of specific neuroimaging markers |
| Assessment of white matter tracts through DTI |
| Functional connectivity analysis through fMRI |
| Supporting comprehensive diagnostic approach |
MRI Findings in Frontal Lobe Disorders
Frontal lobe disorders, including frontotemporal dementia (FTD), can have significant impacts on brain structure and function. When examining these disorders using MRI imaging, specific findings and abnormalities are observed that help distinguish them from a normal brain.
One of the main MRI findings in frontal lobe disorders is frontotemporal lobe atrophy. This refers to the shrinkage or loss of volume in the frontal and temporal lobes of the brain, which are prominently affected in FTD. The degree of atrophy in these areas can vary among individuals and can be visually identified on an MRI scan.
In comparison to a normal brain, the MRI findings in frontal lobe disorders, such as FTD, often show significant frontotemporal lobe atrophy. This can be observed as a reduction in the size and thickness of the frontal and temporal lobes, as well as the presence of widened sulci and enlarged ventricles.
Additionally, MRI imaging can reveal other specific markers of frontal lobe disorders, including abnormalities in white matter tracts connecting different regions of the brain, changes in cortical thickness, and alterations in functional connectivity.
It is important to note that the MRI findings in frontal lobe disorders, like FTD, may also overlap with those seen in other neurodegenerative diseases. Therefore, a comprehensive evaluation of clinical symptoms and additional diagnostic tests may be necessary to accurately differentiate between these disorders.
Overall, MRI imaging plays a crucial role in identifying and understanding the unique MRI findings associated with frontal lobe disorders, particularly frontotemporal dementia. It provides valuable visual markers and abnormalities that aid in the diagnosis and management of these conditions, ultimately improving patient care and treatment outcomes.
Differentiating Dementia Brain Scans
When it comes to understanding and diagnosing dementia, brain scans play a crucial role. In this section, we will explore the differences observed in brain scans between individuals with dementia, specifically frontotemporal dementia (FTD), and those with a normal brain. By analyzing these distinct characteristics and patterns through MRI imaging, healthcare professionals can gain valuable insights into the underlying changes in the brain.
Distinctive Features in Dementia Brain Scans
Dementia brain scans, including those of patients with FTD, exhibit certain marked differences compared to normal brain scans. These variations can be observed in several key areas, which provide critical clues for diagnosing and differentiating dementia conditions.
- Differing Levels of Atrophy: One prominent difference in dementia brain scans is the presence of atrophy, particularly in the frontal and temporal lobes. Frontotemporal dementia, in particular, shows significant atrophy in these regions, with a visibly reduced volume compared to a normal brain.
- Abnormal Connectivity Patterns: Another distinguishing characteristic of dementia brain scans is the altered connectivity patterns observed between different brain regions. These disruptions in neural networks can be detected through advanced imaging techniques, such as functional MRI (fMRI), which highlight the abnormal synchronization and communication within the brain.
- Structural Abnormalities: Structural abnormalities, such as the presence of lesions, white matter changes, and cortical thinning, are often evident in dementia brain scans. These anomalies further contribute to the differentiation between a dementia-affected brain and a normal brain.
Cases of Frontotemporal Dementia vs. Normal Brain
In the frontotemporal dementia brain scan, you can observe the significant atrophy in the frontal and temporal lobes, as well as the altered connectivity patterns within the brain. These visual markers are indicative of the presence of frontotemporal dementia and help healthcare professionals in accurate diagnosis and monitoring of the disease.
Radiological Features of Frontotemporal Dementia
Frontotemporal dementia (FTD) can be distinguished from a normal brain scan through specific radiological features identified during MRI imaging. These markers play a crucial role in diagnosing and understanding the progression of FTD. By analyzing the radiological findings, clinicians can accurately differentiate FTD from a normal brain and tailor treatment plans accordingly.
Key Radiological Features
When examining MRI scans of patients with frontotemporal dementia, several distinct features can be observed:
- Frontotemporal lobe atrophy: One of the most prominent radiological features in FTD is the significant loss of brain tissue in the frontotemporal lobes. This atrophy affects the frontal and temporal regions, leading to cognitive and behavioral changes.
- Enlargement of the ventricles: In FTD, the ventricles, which are fluid-filled spaces in the brain, may appear larger than normal on MRI scans. This enlargement is associated with the loss of brain tissue.
- White matter abnormalities: MRI imaging can reveal disruptions in the white matter tracts of the brain in individuals with FTD. These abnormalities contribute to the impaired connectivity between different brain regions.
- Abnormalities in the basal ganglia: The basal ganglia, responsible for regulating movement and emotions, may show abnormalities in FTD patients. These changes contribute to the motor and behavioral symptoms observed in the disease.
By carefully examining these radiological features, healthcare professionals can confidently diagnose frontotemporal dementia and differentiate it from other neurodegenerative disorders.
| Radiological Features | Frontotemporal Dementia | Normal Brain |
|---|---|---|
| Frontotemporal Lobe Atrophy | Present | Absent |
| Ventricular Enlargement | May be present | Absent |
| White Matter Abnormalities | Observed | Absent |
| Basal Ganglia Abnormalities | May be present | Absent |
This table highlights the contrasting radiological features between frontotemporal dementia and a normal brain. These distinctions enable healthcare providers to accurately interpret MRI scans and make informed decisions regarding appropriate treatment strategies.
Comparing Neuroimaging Findings
Neuroimaging plays a crucial role in the diagnosis and understanding of frontotemporal dementia (FTD) and other forms of dementia. By analyzing MRI scans, healthcare professionals can identify distinct patterns and markers that differentiate FTD from other types of dementia. This section aims to provide a comprehensive comparison of neuroimaging findings in FTD and explores the similarities and differences observed in the MRI scans of various forms of dementia.
Neuroimaging Findings in Frontotemporal Dementia
When examining MRI scans of individuals with frontotemporal dementia, certain characteristic patterns can be observed. One key finding is the significant atrophy or shrinkage of the frontotemporal lobes. This atrophy often affects the frontal and temporal regions of the brain, leading to notable changes in the structure and functioning of these areas.
In addition to lobar atrophy, neuroimaging in frontotemporal dementia may reveal hypometabolism, which refers to decreased glucose metabolism in affected brain regions. This metabolic dysfunction can be detected using PET scans, providing valuable insights into the underlying pathology of FTD.
Dementia Neuroimaging Comparison
Comparing the neuroimaging findings in frontotemporal dementia with other forms of dementia allows for a better understanding of the specific brain changes associated with each condition. While there are similarities in certain structural abnormalities across different dementia types, there are also notable differences that aid in accurate diagnosis and differentiation.
For example, in Alzheimer’s disease, neuroimaging often reveals widespread cortical atrophy, whereas FTD primarily affects the frontal and temporal lobes. Vascular dementia, on the other hand, shows signs of focal brain lesions or infarctions due to cerebrovascular disease.
By examining these unique neuroimaging features, clinicians can distinguish between different types of dementia and tailor treatments and interventions accordingly. The table below summarizes the key neuroimaging findings in FTD contrasted with other forms of dementia:
| Type of Dementia | Neuroimaging Findings |
|---|---|
| Frontotemporal Dementia (FTD) | Frontotemporal lobe atrophy, hypometabolism, specific patterns of cortical thinning |
| Alzheimer’s Disease | Widespread cortical atrophy, hippocampal volume loss, beta-amyloid plaques, neurofibrillary tangles |
| Vascular Dementia | Focal brain lesions, infarctions, white matter changes, lacunar infarcts |
| Lewy Body Dementia | Lewy bodies in cortical regions, reduced dopamine transporter uptake in basal ganglia |
By analyzing these distinct neuroimaging features, healthcare professionals can enhance their diagnostic accuracy and provide appropriate care and support for individuals with frontotemporal dementia and other forms of dementia.
Understanding the Significance of MRI Markers
MRI markers play a crucial role in the diagnosis and monitoring of frontotemporal dementia (FTD). These specific imaging markers provide valuable insights into the disease progression, enabling healthcare professionals to better understand and manage this condition.
One of the key MRI markers associated with FTD is frontotemporal lobe atrophy. During an MRI scan, this marker is characterized by a significant reduction in the size of the frontotemporal lobes compared to a normal brain. This atrophy is often asymmetrical, affecting one side more than the other.
In addition to frontotemporal lobe atrophy, other imaging markers of FTD may include:
- Changes in the shape and size of the hippocampus, which is responsible for memory and learning
- Abnormalities in the structure and function of the prefrontal cortex, leading to cognitive and behavioral symptoms
- Disruptions in the white matter tracts that connect different brain regions, affecting communication between these areas
These MRI markers provide important diagnostic information, allow for the differentiation of FTD from normal brain scans, and aid in the identification of specific subtypes within the FTD spectrum.
MRI Markers of Frontotemporal Dementia
| Marker | Description |
|---|---|
| Frontotemporal lobe atrophy | Significant reduction in the size of the frontotemporal lobes, often asymmetrical |
| Hippocampal changes | Alterations in the shape and size of the hippocampus, impacting memory and learning |
| Prefrontal cortex abnormalities | Structural and functional disruptions in the prefrontal cortex, leading to cognitive and behavioral symptoms |
| White matter tract disruptions | Irregularities in the white matter tracts that connect different brain regions, affecting communication |
By analyzing these MRI markers, healthcare professionals can make accurate diagnoses, monitor disease progression, and develop personalized treatment plans for individuals with frontotemporal dementia.
Frontotemporal Dementia vs Normal Brain: A Visual Comparison
In order to understand the distinct differences between a brain affected by frontotemporal dementia (FTD) and a normal brain, we turn to the powerful imaging capabilities of MRI. This technology allows us to visually examine and compare the structural changes in these two brain types.
When conducting an MRI scan of a frontotemporal dementia brain, several visual markers become apparent. One of the key features is the noticeable atrophy, or shrinkage, of the frontotemporal lobe. This area of the brain is responsible for functions such as decision-making, personality, and language.
In contrast, a normal brain scan reveals a healthy frontotemporal lobe without any significant signs of atrophy. This visual comparison highlights the striking contrast between the two brain types and the impact frontotemporal lobe atrophy has on individuals with FTD.
To further illustrate this comparison, let’s take a closer look at the specific areas of atrophy and their implications:
| FTD Brain | Normal Brain |
|---|---|
| Frontotemporal lobe exhibits significant atrophy and shrinkage | Frontotemporal lobe appears healthy and intact |
| Changes in personality, behavior, and speech may manifest | No significant changes in personality, behavior, or speech patterns |
| Impaired decision-making and problem-solving abilities | No notable impairment in decision-making or problem-solving |
This side-by-side comparison allows us to visually comprehend the stark differences between a frontotemporal dementia brain and a normal brain. By identifying the specific areas of atrophy and the subsequent impact on cognitive functions, we gain a deeper understanding of the challenges faced by individuals with FTD.
Interpreting MRI Results for FTD
When it comes to diagnosing frontotemporal dementia (FTD), MRI scans play a crucial role in providing valuable insights into the condition. Healthcare professionals carefully evaluate these MRI results to identify specific brain changes that can confirm or rule out FTD.
During the interpretation process, several important factors are considered. First, the overall structure of the brain is examined to compare it with a normal brain scan. In frontotemporal dementia, specific areas of the brain, such as the frontal and temporal lobes, may show atrophy or shrinkage in comparison to a healthy brain.
Diagnosing FTD with MRI entails a thorough analysis of the patterns and characteristics observed in the scan. Radiologists and neurologists look for frontotemporal lobe atrophy as a primary marker of FTD. Atrophy in these regions indicates the degeneration of neurons and the underlying pathology of the condition.
Another crucial aspect of interpreting MRI results is examining the relationship between brain structure and function. While MRI scans primarily provide structural information, functional MRI (fMRI) scans can also be employed to evaluate brain activity. This comprehensive approach helps healthcare professionals gain a better understanding of the impact of FTD on an individual’s cognition and behavior.
It’s worth noting that MRI results, while instrumental, are not the sole determining factor in diagnosing FTD. Healthcare professionals consider a combination of clinical assessments, neurological examinations, and medical history to arrive at an accurate diagnosis. However, frontotemporal dementia MRI findings offer vital insights into the presence and progression of the disease.
| Factors Considered in MRI Interpretation for FTD Diagnosis |
|---|
| 1. Frontotemporal lobe atrophy |
| 2. Comparison with a normal brain scan |
| 3. Examination of structural brain changes |
| 4. Assessment of functional brain activity (if applicable) |
Importance of Early Detection through MRI
Early detection plays a critical role in the diagnosis and management of frontotemporal dementia (FTD). Through the use of MRI imaging, healthcare professionals can identify and analyze the distinct brain changes associated with FTD, allowing for accurate diagnosis and timely interventions.
One of the key indicators of FTD is frontotemporal lobe atrophy, which can be visualized through MRI scans. By comparing the MRI findings of a patient with suspected FTD to those of a normal brain, healthcare professionals can identify significant differences and patterns that indicate the presence of the disease. This frontotemporal lobe atrophy comparison helps in distinguishing FTD from a normal brain scan.
Early detection through MRI offers several benefits for individuals with suspected FTD. Firstly, it allows for a more accurate diagnosis, enabling healthcare professionals to differentiate between FTD and other types of dementia. This distinction is crucial as it guides treatment decisions and helps develop personalized care plans.
Secondly, early detection provides an opportunity for timely interventions and support. With a better understanding of the disease progression, healthcare professionals can offer appropriate therapies, medications, and cognitive interventions that can improve quality of life and slow down symptom progression.
The use of MRI in the early detection of FTD also allows for the inclusion of patients in clinical trials and research studies. This participation contributes to the advancement of knowledge and the development of new treatment strategies.
In summary, early detection through MRI imaging plays a vital role in the diagnosis and management of frontotemporal dementia. By utilizing frontotemporal lobe atrophy comparison and analyzing distinct brain changes associated with FTD, healthcare professionals can accurately diagnose the disease, provide timely interventions, and improve the overall prognosis for individuals with FTD.
Advances in MRI Technology for FTD Diagnosis
The field of MRI technology has witnessed significant advancements that have revolutionized the accuracy and efficiency of frontotemporal dementia (FTD) diagnosis. These advancements have enabled healthcare professionals to capture detailed imaging of the frontal lobe, providing valuable insights into the diagnosis and progression of FTD. Frontotemporal Dementia MRI vs Normal Comparison
Specific techniques and protocols have been developed to enhance the visualization of MRI findings in frontal lobe disorders. These advancements allow for the detection of subtle changes in brain structure and function, enabling a more precise differentiation between FTD and a normal brain. Frontotemporal Dementia MRI vs Normal Comparison
By leveraging these cutting-edge MRI technologies, healthcare providers can identify unique markers and patterns associated with FTD, such as frontotemporal lobe atrophy, which further aids in the accurate diagnosis of the condition. The ability to distinguish FTD from a normal brain through MRI findings plays a crucial role in providing timely interventions and personalized treatment plans for patients. Frontotemporal Dementia MRI vs Normal Comparison
FAQ
What are the main differences between the MRI of a brain with frontotemporal dementia (FTD) and a normal brain?
In an MRI scan, a brain with frontotemporal dementia (FTD) typically shows specific markers, such as frontotemporal lobe atrophy and other radiological features. These markers differentiate it from a normal brain scan, which does not exhibit these abnormalities. MRI imaging provides valuable insights into the structural changes associated with FTD.
What is frontotemporal dementia and how does it compare to a normal brain?
Frontotemporal dementia (FTD) is a neurodegenerative disease that affects the frontal and temporal lobes of the brain. In FTD, these regions exhibit atrophy and other abnormalities, leading to behavioral and cognitive changes. This contrasts with a normal brain, which does not show such degeneration and maintains typical functioning in these areas.
How does MRI play a role in diagnosing frontotemporal dementia?
MRI scans, particularly when performed by experts like Acibadem Healthcare Group, play a crucial role in diagnosing frontotemporal dementia. These scans allow healthcare professionals to detect and evaluate the structural changes associated with FTD, aiding in the accurate diagnosis of the condition. MRI imaging provides valuable neuroimaging markers that contribute to the diagnostic process.
What specific findings can be observed in MRI scans of frontal lobe disorders, including frontotemporal dementia?
MRI scans of frontal lobe disorders, such as frontotemporal dementia, can reveal specific findings, such as frontotemporal lobe atrophy, hypometabolism, and white matter alterations. These findings indicate the presence of degeneration and abnormalities in the frontal lobes, distinguishing them from a normal brain scan.
How do brain scans of individuals with dementia differ from those with a normal brain?
Brain scans of individuals with dementia, including frontotemporal dementia, exhibit distinct differences from those with a normal brain. These differences include atrophy, reduced brain volume, and alterations in specific brain regions. MRI imaging plays a crucial role in identifying these differences and aiding in the diagnosis of dementia.
What are the radiological features associated with frontotemporal dementia?
Frontotemporal dementia exhibits specific radiological features that can be identified through MRI imaging. These features include frontotemporal lobe atrophy, ventricular enlargement, and cortical thinning. These markers are instrumental in distinguishing frontotemporal dementia from a normal brain scan.
How do the neuroimaging findings in frontotemporal dementia compare to other forms of dementia?
Neuroimaging findings in frontotemporal dementia can differ from those in other forms of dementia. While there may be some similarities, such as overall brain atrophy, frontotemporal dementia typically presents with distinct brain changes in the frontal and temporal lobes. Comparing the neuroimaging characteristics of different types of dementia can provide valuable insights into their unique features.
What is the significance of MRI markers in frontotemporal dementia diagnosis?
MRI markers in frontotemporal dementia play a critical role in the diagnosis and monitoring of the condition. These markers provide visual evidence of the structural changes associated with FTD, which aids in confirming the diagnosis. Additionally, MRI markers help track disease progression over time, guiding treatment decisions and interventions.
How does a frontotemporal dementia brain compare visually to a normal brain through MRI imaging?
Through MRI imaging, a frontotemporal dementia brain visually displays distinct differences from a normal brain. These differences include frontotemporal lobe atrophy, cortical thinning, and other radiological abnormalities. Comparing the two visually allows healthcare professionals to identify the specific areas of atrophy and abnormality in the frontotemporal lobe, highlighting the contrast between FTD and a healthy brain.
How do healthcare professionals interpret MRI results for the diagnosis of frontotemporal dementia?
Healthcare professionals interpret MRI results for the diagnosis of frontotemporal dementia by examining specific markers, such as frontotemporal lobe atrophy, ventricular enlargement, and cortical thinning. They evaluate the severity and distribution of these markers to determine the presence and progression of FTD. Expertise in interpreting MRI scans is crucial to accurately diagnose and manage frontotemporal dementia.
Why is early detection of frontotemporal dementia important, and how can MRI contribute to this?
Early detection of frontotemporal dementia is essential for accurate diagnosis and timely interventions. Recognizing the distinct brain changes associated with FTD at an early stage allows for better management of symptoms and the implementation of appropriate support systems. MRI imaging plays a critical role in facilitating early detection by providing valuable insights into the structural abnormalities associated with FTD.
What advances in MRI technology have improved frontotemporal dementia diagnosis?
Advances in MRI technology have significantly improved the accuracy and efficiency of frontotemporal dementia diagnosis. Techniques such as high-resolution imaging, diffusion tensor imaging, and functional MRI contribute to capturing detailed images of the frontal lobe and detecting specific abnormalities associated with FTD. These advancements have enhanced the ability to distinguish FTD from a normal brain and aid in early detection.
ACIBADEM Healthcare Group Hospitals and Clinics
With a network of hospitals and clinics across 5 countries, including 40 hospitals, ACIBADEM Healthcare Group has a global presence that allows us to provide comprehensive healthcare services to patients from around the world. With over 25,000 dedicated employees, we have the expertise and resources to deliver unparalleled healthcare experiences. Our mission is to ensure that each patient receives the best possible care, supported by our commitment to healthcare excellence and international healthcare standards. Ready to take the first step towards a healthier future? Contact us now to schedule your Free Consultation Health session. Our friendly team is eager to assist you and provide the guidance you need to make informed decisions about your well-being. Click To Call Now !*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of ACIBADEM Health Group.